Scientific publications

Emergence of secondary acute leukemia in a patient treated for osteosarcoma: implications of germline TP53 mutations

Panizo C, Patiño A [SP], Calasanz MJ, Rifón J, Sierrasesumaga L, Rocha E.
Department of Hematology, University Clinic of Navarra, School of Medicine, University of Navarra, Pamplona, Spain.

Magazine: Medical and Pediatric Oncology

Date: Mar 1, 1998

Pediatrics [SP] Haematology and Hameotherapy

BACKGROUND
Secondary leukemia and myelodysplastic syndromes have been reported in patients following treatment for a wide range of neoplastic disorders. However second malignancies after chemotherapy and/or irradiation for osteosarcoma are unusual.

PROCEDURE
We report the case of a 15-year-old girl who developed a myelodysplastic syndrome with evolution to acute nonlymphocytic leukemia after treatment for osteosarcoma. Therapy-related acute leukemia karyotype findings such as abnormalities of chromosomes 5, 7, and 17 were found in the cytogenetic analysis. Moreover, using denaturing gradient gel electrophoresis and DNA sequencing, we detected the presence of a double germline mutation in exon 7 of the TP53 gene.

CONCLUSION
This observation supports the possibility of a causal relationship between germline TP53 mutations and the development of secondary leukemia and myelodysplasia.

CITATION  Med Pediatr Oncol. 1998 Mar;30(3):165-9

you mayBE INTERESTED

WHAT TECHNOLOGY
DO WE USE?

The Clínica is the greater private hospital with technological equipment of Spain, all in a single center.

Imagen de un PET, tecnología de vanguardia en la Clínica Universidad de Navarra

OUR
PROFESSIONALS

The professionals of the Clínica perform continuous research and training, always to the benefit of the patient.

Imagen profesionales de la Clínica Universidad de Navarra

WHY CHOOSE
THE CLINICA?

Learn why we are different from other healthcare centers. Quality, speed, comfort and results.

Imagen del edificio de la Clínica Universidad de Navarra